1. Home
  2. PED vs NTRB Comparison

PED vs NTRB Comparison

Compare PED & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pedevco Corp.

PED

Pedevco Corp.

HOLD

Current Price

$0.58

Market Cap

52.2M

Sector

Energy

ML Signal

HOLD

Logo Nutriband Inc.

NTRB

Nutriband Inc.

HOLD

Current Price

$4.60

Market Cap

57.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PED
NTRB
Founded
N/A
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Industrial Specialties
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.2M
57.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PED
NTRB
Price
$0.58
$4.60
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$1.50
N/A
AVG Volume (30 Days)
117.4K
63.5K
Earning Date
11-17-2025
12-11-2025
Dividend Yield
N/A
N/A
EPS Growth
156.43
N/A
EPS
0.11
N/A
Revenue
$33,244,999.00
$2,278,321.00
Revenue This Year
N/A
$30.17
Revenue Next Year
$305.89
$3,394.36
P/E Ratio
$5.52
N/A
Revenue Growth
N/A
12.69
52 Week Low
$0.43
$4.17
52 Week High
$0.94
$11.78

Technical Indicators

Market Signals
Indicator
PED
NTRB
Relative Strength Index (RSI) 59.17 49.58
Support Level $0.53 $4.25
Resistance Level $0.59 $4.85
Average True Range (ATR) 0.03 0.25
MACD 0.00 0.06
Stochastic Oscillator 85.91 63.24

Price Performance

Historical Comparison
PED
NTRB

About PED Pedevco Corp.

PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.

About NTRB Nutriband Inc.

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Share on Social Networks: